Aboulker JP - Search Results

1

Intermittent antiretroviral therapy in patients with controlled HIV infection.

Marchou B, Tangre P, Charreau I, Izopet J, Girard PM, May T, Ragnaud JM, Aboulker JP, Molina JM; ANRS 106 Study team. Marchou B, et al. Among authors: aboulker jp. AIDS. 2007 Feb 19;21(4):457-66. doi: 10.1097/QAD.0b013e328013d9eb. AIDS. 2007. PMID: 17301564 Clinical Trial.

2

Final analysis of the Trilège induction-maintenance trial: results at 18 months.

Flandre P, Raffi F, Descamps D, Calvez V, Peytavin G, Meiffredy V, Harel M, Hazebrouck S, Pialoux G, Aboulker JP, Brun Vezinet F. Flandre P, et al. Among authors: aboulker jp. AIDS. 2002 Mar 8;16(4):561-8. doi: 10.1097/00002030-200203080-00007. AIDS. 2002. PMID: 11872999 Clinical Trial.

3

Increased risk of lipoatrophy under stavudine in HIV-1-infected patients: results of a substudy from a comparative trial.

Joly V, Flandre P, Meiffredy V, Leturque N, Harel M, Aboulker JP, Yeni P. Joly V, et al. Among authors: aboulker jp. AIDS. 2002 Dec 6;16(18):2447-54. doi: 10.1097/00002030-200212060-00010. AIDS. 2002. PMID: 12461419 Clinical Trial.

4

Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine or stavudine, each in combination with lamivudine and indinavir.

Descamps D, Flandre P, Joly V, Meiffrédy V, Peytavin G, Izopet J, Tamalet C, Zeng AF, Harel M, Lastère S, Aboulker JP, Yéni P, Brun-Vézinet F; NOVAVIR (ANRS 073) Study Group. Descamps D, et al. Among authors: aboulker jp. J Acquir Immune Defic Syndr. 2002 Dec 15;31(5):464-71. doi: 10.1097/00126334-200212150-00002. J Acquir Immune Defic Syndr. 2002. PMID: 12473833 Clinical Trial.

5

Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection: a randomized controlled trial.

Levy Y, Durier C, Krzysiek R, Rabian C, Capitant C, Lascaux AS, Michon C, Oksenhendler E, Weiss L, Gastaut JA, Goujard C, Rouzioux C, Maral J, Delfraissy JF, Emilie D, Aboulker JP; ANRS 079 Study Group. Levy Y, et al. Among authors: aboulker jp. AIDS. 2003 Feb 14;17(3):343-51. doi: 10.1097/00002030-200302140-00008. AIDS. 2003. PMID: 12556688 Clinical Trial.

6

Predictive factors and selection of thymidine analogue mutations by nucleoside reverse transcriptase inhibitors according to initial regimen received.

Flandre P, Descamps D, Joly V, Meiffrédy V, Tamalet C, Izopet J, Aboulker JP, Brun-Vézinet F. Flandre P, et al. Among authors: aboulker jp. Antivir Ther. 2003 Feb;8(1):65-72. Antivir Ther. 2003. PMID: 12713066 Clinical Trial.

7

Interactions between atazanavir-ritonavir and tenofovir in heavily pretreated human immunodeficiency virus-infected patients.

Taburet AM, Piketty C, Chazallon C, Vincent I, Gérard L, Calvez V, Clavel F, Aboulker JP, Girard PM. Taburet AM, et al. Among authors: aboulker jp. Antimicrob Agents Chemother. 2004 Jun;48(6):2091-6. doi: 10.1128/AAC.48.6.2091-2096.2004. Antimicrob Agents Chemother. 2004. PMID: 15155205 Free PMC article. Clinical Trial.

8

Virological and immunological impact of non-nucleoside reverse transcriptase inhibitor withdrawal in HIV-infected patients with multiple treatment failures.

Piketty C, Gérard L, Chazallon C, Calvez V, Clavel F, Taburet AM, Girard PM, Aboulker JP; ANRS 107 Puzzle 2 Study Group. Piketty C, et al. Among authors: aboulker jp. AIDS. 2004 Jul 2;18(10):1469-71. doi: 10.1097/01.aids.0000131340.68666.21. AIDS. 2004. PMID: 15199325 Clinical Trial.

9

Immunological and virological efficacy of a therapeutic immunization combined with interleukin-2 in chronically HIV-1 infected patients.

Lévy Y, Gahéry-Ségard H, Durier C, Lascaux AS, Goujard C, Meiffrédy V, Rouzioux C, El Habib R, Beumont-Mauviel M, Guillet JG, Delfraissy JF, Aboulker JP; ANRS 093 Study Group. Lévy Y, et al. Among authors: aboulker jp. AIDS. 2005 Feb 18;19(3):279-86. AIDS. 2005. PMID: 15718838 Clinical Trial.

10

Contribution of cellular HIV-1 DNA quantification to the efficacy analysis of antiretroviral therapy: a randomized comparison of 2 regimens, including 3 drugs from 2 or 3 classes (TRIANON, ANRS 081).

Morand-Joubert L, Marcellin F, Launay O, Guiramand-Hugon S, Gérard L, Yeni P, Aboulker JP; Agence Nationale de Recherches sur le SIDA 081 Study Group. Morand-Joubert L, et al. Among authors: aboulker jp. J Acquir Immune Defic Syndr. 2005 Mar 1;38(3):268-76. J Acquir Immune Defic Syndr. 2005. PMID: 15735443 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters